Elsevier relaunches biomedical database ‘Embase’
<br />
<br />STM publisher Elsevier, Netherlands, has announced a re-launch of Embase, its biomedical database which holds over 20 million indexed records from more than 7,000 active, peer-reviewed journals.
<br />
<br />Embase claims to have played a key role in the advancement of new biomedical and pharmaceutical insights. New developments and updates include enabling all biomedical researchers to use Embase - extending its ‘usability’ from information specialists to also include all biomedical and pharmaceutical scientists, and clinical and regulatory professionals. New retrieval tools help further drive discovery, including quick and easy refining of search results and the display of indexed drug-drug and drug-disease relations. Indexed articles-in-press and conference abstracts have also been added to improve comprehensiveness. To signify the enhanced focus on biomedical answers, the product now has a new, fresh look and feel to it, according to Elsevier.
<br />
<br />Embase seeks to support researchers with key tasks such as tracking of drug adverse events, comparing drug therapies, and Evidence Based Medicine research. It aims to provide researchers with insights and understanding from the world’s life sciences information, enabling effective discoveries towards medical discovery and treatment.
<br />
<br />SOURCE LINK: http://www.knowledgespeak.com/newsArchieveviewdtl.asp?pickUpID=9271&pickUpBatch=1317#9271
<br />
<br />Best Regards,
<br />Raghavendra R<br />-- 
<br />This message has been scanned for viruses and
<br />dangerous content by
<a href="http://www.mailscanner.info/"><b>MailScanner</b></a>, and is
<br />believed to be clean.